GOSS vs NWSA · rev $26.2M vs rev $9.03B
Gossamer Bio Inc (GOSS) versus NWSA (NWSA) — a side-by-side from cached financials, not a winner call.
Gossamer Bio Inc (GOSS) is a biotechnology company listed on US.
NWSA (NWSA) common stock.
Latest reported GOSS revenue for 2026-06-30 was $26.2M. Net income was -$29.8M. Revenue was up 54.5% from 2026-03-31 to 2026-06-30. GOSS currently screens at market cap $47.0M.
Latest reported NWSA revenue for 2026-06-30 was $9.03B. Net income was $573.0M. Revenue was up 328.1% from 2025-06-30 to 2026-06-30. NWSA currently screens at market cap $0.
GOSS currently screens at market cap $47.0M. NWSA currently screens at market cap $0.
Not investment advice. Open the GOSS and NWSA stock pages for the full models.
Not investment advice.